Targeted nanocarriers coopting pulmonary leukocytes for drug delivery to the injured brain
Patrick M. Glassman(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(University of Pennsylvania), Colin F. Greineder(Translational Therapeutics (United States)), Scott E. Kasner(University of Pennsylvania), Alvin J. Mukalel(University of Pennsylvania), Viviana Zuluaga‐Ramirez(Temple University), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Raisa Y. Kiseleva(Translational Therapeutics (United States)), Serena Omo‐Lamai(University of Pennsylvania), Yuri Persidsky(Temple College), Carlos H. Villa(Center for Biologics Evaluation and Research), Jacob W. Myerson(Translational Therapeutics (United States)), Drew Weissman(California University of Pennsylvania), Jia Nong(University of Pennsylvania), Michael J. Mitchell(California Institute for Regenerative Medicine), Silvia Muro(Institució Catalana de Recerca i Estudis Avançats), Alba Rodríguez-García(Fundació Clínic per a la Recerca Biomèdica), Landis R. Walsh(Translational Therapeutics (United States))
Cited by 3
Related Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
|Stroke|2010|1.5k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940